KKUR ChromoCure, Inc. (PNK) at $0.000001 on 08 Jan 2026: top gainer risk check
KKUR stock jumped to $0.000001 during U.S. market hours on 08 Jan 2026, marking it among the session’s top gainers. Volume reached 1,500,065 shares versus a 3-month average near 2,900,052, showing elevated intraday interest. The microcap trade reflects speculative flows into ChromoCure, Inc. (PNK) rather than new fundamental releases. We examine trading drivers, company fundamentals, and technical signals to frame the risk-adjusted outlook for investors
KKUR stock intraday move and liquidity
ChromoCure, Inc. (KKUR) traded between $0.000001 and $0.000002 intraday on 08 Jan 2026, with the session open at $0.000002. Reported volume was 1,500,065, below the average of 2,900,052, so price moves can be volatile. Market cap stands at $8,200 with 8,200,000,000 shares outstanding, indicating extreme microcap status and low free-float liquidity
Company profile and sector context for KKUR stock
ChromoCure, Inc. operates in Healthcare, Medical – Specialties, developing the Chromosomal Scanner Series 200 for cancer detection. The firm lists on the PNK exchange in the United States and reports just 4 full-time employees. Sector peers typically show revenue and clinical milestones; KKUR lacks recent filings and public revenue figures, which increases disclosure risk compared with larger healthcare names
Fundamentals, ratios and what the numbers show
Key ratios are largely unavailable: EPS and P/E are N/A, and reported price averages for 50 and 200 days are $0.000001. The 52-week range is $0.000001 to $0.000002. These inputs show limited trading history and negligible reported earnings, so valuation using traditional multiples is not feasible. Investors should treat listed metrics as incomplete for standard fundamental valuation
Technical and volume signals for KKUR stock
Available technical indicators are non-informative: RSI, MACD and ATR read near zero in the data feed, reflecting sparse price history and low-quality time series. On microcaps like ChromoCure, single trades can swing price drastically. Relative volume is 0.52, indicating current flow is about half the average; that combination typically increases short-term volatility rather than confirming a sustained trend
Meyka AI grade and analyst framing for KKUR stock
Meyka AI rates KKUR with a score out of 100: 62.75 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade reflects microcap risk, limited disclosure, and isolated trading patterns. These grades are not guaranteed and are informational only; they do not constitute investment advice
Catalysts, risks and opportunities for KKUR stock
Opportunities would require clear clinical data or a definitive corporate update; absent that, trading interest is speculative. Major risks include thin liquidity, limited public financials, and reliance on a single product concept. Upside catalysts are corporate filings, clinical milestones, or partnership announcements. Short-term traders should expect wide intraday spreads and potential for sharp reversals
Final Thoughts
KKUR stock is trading at $0.000001 on the PNK exchange in the United States with a microcap market cap of $8,200 and intraday volume of 1,500,065. Our technical and fundamental checks show limited public data, no EPS or P/E, and sparse indicator signals, which raises execution and disclosure risk. Meyka AI’s forecast model projects a baseline scenario near $0.000010, implying an implied upside of roughly 900.00% from the current price, while a conservative short-term target of $0.000002 implies 100.00% upside and an aggressive scenario of $0.000050 implies 4,900.00% upside. Forecasts are model-based projections and not guarantees. For most investors, KKUR represents a high-risk speculative position best sized as a small allocation within a diversified portfolio. We track this microcap on the Meyka AI platform for real-time updates and model revisions
FAQs
What caused KKUR stock to spike today
The intraday move to $0.000001 appears driven by speculative trading and volume pickup rather than a public company announcement. Microcap names can move sharply on limited order flow
What is Meyka AI’s view on KKUR stock valuation
Meyka AI highlights missing earnings and ratios; with EPS and P/E listed as N/A, traditional valuation is not possible. The proprietary grade is B with a HOLD suggestion given disclosure gaps
How should investors approach KKUR stock
Treat KKUR as a high-risk speculative trade. Size positions small, expect wide spreads, and wait for clear corporate updates or filings before increasing exposure
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
